{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T04:59:30Z","timestamp":1774414770056,"version":"3.50.1"},"reference-count":159,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Future Cardiol."],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.2217\/fca.10.6","type":"journal-article","created":{"date-parts":[[2010,5,12]],"date-time":"2010-05-12T12:35:45Z","timestamp":1273667745000},"page":"409-424","source":"Crossref","is-referenced-by-count":20,"title":["Implementing genotype-guided Antithrombotic Therapy"],"prefix":"10.1080","volume":"6","author":[{"given":"Richard L","family":"Seip","sequence":"first","affiliation":[{"name":"Genomas Inc. 67 Jefferson Street Hartford CT 06106 USA; and President & CEO Genomas Inc. Director of Genetics Research Hartford Hospital 67 Jefferson Street Hartford CT 06106 USA"},{"name":"Department of Cardiology Hartford Hospital Hartford CT 06102 USA"},{"name":"Genetics Research Center Hartford Hospital Hartford CT 06102 USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Duconge","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences University of Puerto Rico San Juan PR 00936\u20135067 USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gualberto","family":"Rua\u00f1o","sequence":"additional","affiliation":[{"name":"Genomas Inc. 67 Jefferson Street Hartford CT 06106 USA; and President & CEO Genomas Inc. Director of Genetics Research Hartford Hospital 67 Jefferson Street Hartford CT 06106 USA"},{"name":"Genetics Research Center Hartford Hospital Hartford CT 06102 USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2010,5,12]]},"reference":[{"key":"e_1_3_2_3_1_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.3_suppl.204S"},{"key":"e_1_3_2_3_2_1","unstructured":"Anonymous : 2008 Top 200 generic drugs by total prescriptions. Drug Topics (2009)."},{"key":"e_1_3_2_3_3_1","unstructured":"McWilliam A LutterR and Nardinelli C: Health care savings from personalized medicine using genetic testing: the case of warfarin. AEI-Brookings Joint Center Working Paper 06\u201323 (2006)."},{"key":"e_1_3_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.13.1690"},{"key":"e_1_3_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000433"},{"key":"e_1_3_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-134247"},{"key":"e_1_3_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2006.02679.x"},{"key":"e_1_3_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1025052827305"},{"key":"e_1_3_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199402000-00005"},{"key":"e_1_3_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2002.129321"},{"key":"e_1_3_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH04-08-0542"},{"key":"e_1_3_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.2217\/17410541.5.3.225"},{"key":"e_1_3_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1053\/cp.1999.v66.100072001"},{"key":"e_1_3_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.109.029132"},{"key":"e_1_3_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-003-0606-2"},{"issue":"4","key":"e_1_3_2_3_16_1","first-page":"425","article-title":"Genetic polymorphisms of cytochromes P450: CYP2C9, CYP2C19, and CYP2D6 in Croatian population.","volume":"44","author":"Bozina N","year":"2003","unstructured":"Bozina N , GranicP, LalicZ, TramisakI, LovricM, Stavljenic-RukavinaA: Genetic polymorphisms of cytochromes P450: CYP2C9, CYP2C19, and CYP2D6 in Croatian population.Croat. Med. J., 44(4), 425\u2013428 (2003).","journal-title":"Croat. Med. J."},{"key":"e_1_3_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-003-0588-0"},{"key":"e_1_3_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-005-0938-1"},{"key":"e_1_3_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.9.2.169"},{"key":"e_1_3_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199608000-00007"},{"key":"e_1_3_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199610000-00007"},{"key":"e_1_3_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1998.9992"},{"key":"e_1_3_2_3_23_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1472-8206.2003.00148.x"},{"key":"e_1_3_2_3_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-8206.2004.00307.x"},{"key":"e_1_3_2_3_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-005-0976-8"},{"key":"e_1_3_2_3_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cccn.2004.04.028"},{"key":"e_1_3_2_3_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199806000-00001"},{"key":"e_1_3_2_3_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ftd.0000153402.91854.42"},{"key":"e_1_3_2_3_29_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.09.71"},{"key":"e_1_3_2_3_30_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2002.01604.x"},{"key":"e_1_3_2_3_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-002-0518-6"},{"key":"e_1_3_2_3_32_1","doi-asserted-by":"publisher","DOI":"10.2174\/157488407779422302"},{"key":"e_1_3_2_3_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2005.04.019"},{"key":"e_1_3_2_3_34_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.0306-5251.2001.01460.x"},{"key":"e_1_3_2_3_35_1","doi-asserted-by":"publisher","DOI":"10.1139\/y01-065"},{"key":"e_1_3_2_3_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-004-0890-5"},{"key":"e_1_3_2_3_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.03.002"},{"key":"e_1_3_2_3_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.tpj.6500278"},{"issue":"4","key":"e_1_3_2_3_39_1","first-page":"390","article-title":"Prevalence of combinatorial CYP2C9 and VKORC1 genotypes in Puerto Ricans: implications for warfarin management in hispanics.","volume":"19","author":"Duconge J","year":"2009","unstructured":"Duconge J : Prevalence of combinatorial CYP2C9 and VKORC1 genotypes in Puerto Ricans: implications for warfarin management in hispanics.Ethnicity Disease, 19(4), 390\u2013395 (2009).","journal-title":"Ethnicity Disease"},{"key":"e_1_3_2_3_40_1","doi-asserted-by":"publisher","DOI":"10.2217\/17410541.4.1.11"},{"key":"e_1_3_2_3_41_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2006.078139"},{"key":"e_1_3_2_3_42_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-03-1108"},{"key":"e_1_3_2_3_43_1","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.8.7.851"},{"key":"e_1_3_2_3_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10038-005-0354-5"},{"key":"e_1_3_2_3_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.tpj.6500220"},{"key":"e_1_3_2_3_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.tpj.6500313"},{"key":"e_1_3_2_3_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-006-0260-8"},{"key":"e_1_3_2_3_48_1","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.9.10.1445"},{"key":"e_1_3_2_3_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.fpc.0000114760.08559.dc"},{"key":"e_1_3_2_3_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.fpc.0000184955.08453.a8"},{"key":"e_1_3_2_3_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2008.101"},{"key":"e_1_3_2_3_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature02214"},{"key":"e_1_3_2_3_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature02254"},{"key":"e_1_3_2_3_54_1","first-page":"3","article-title":"The biochemical basis of warfarin therapy.","volume":"214","author":"Suttie JW","year":"1987","unstructured":"Suttie JW : The biochemical basis of warfarin therapy.Adv. Exp. Med. Biol., 214, 3\u201316 (1987).","journal-title":"Adv. Exp. Med. Biol."},{"key":"e_1_3_2_3_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddi180"},{"key":"e_1_3_2_3_56_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa044503"},{"key":"e_1_3_2_3_57_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkm929"},{"key":"e_1_3_2_3_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2006.06.009"},{"key":"e_1_3_2_3_59_1","doi-asserted-by":"publisher","DOI":"10.3121\/cmr.2007.724"},{"key":"e_1_3_2_3_60_1","first-page":"179","article-title":"Pharm GKB: the pharmacogenetics and pharmacogenomics knowledge base.","volume":"311","author":"Thorn CF","year":"2005","unstructured":"Thorn CF , KleinTE, AltmanRB: Pharm GKB: the pharmacogenetics and pharmacogenomics knowledge base.Methods Mol. Biol., 311, 179\u2013191 (2005).","journal-title":"Methods Mol. Biol."},{"key":"e_1_3_2_3_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.223"},{"key":"e_1_3_2_3_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.178"},{"key":"e_1_3_2_3_63_1","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.8.7.713"},{"key":"e_1_3_2_3_64_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.fpc.0000174789.77614.68"},{"key":"e_1_3_2_3_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2005.11.011"},{"key":"e_1_3_2_3_66_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-06-2111"},{"key":"e_1_3_2_3_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.05.005"},{"key":"e_1_3_2_3_68_1","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.9.9.1331"},{"key":"e_1_3_2_3_69_1","doi-asserted-by":"publisher","DOI":"10.3121\/cmr.3.3.137"},{"key":"e_1_3_2_3_70_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.737312"},{"key":"e_1_3_2_3_71_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100316"},{"key":"e_1_3_2_3_72_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-11-122010"},{"key":"e_1_3_2_3_73_1","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.10.2.261"},{"key":"e_1_3_2_3_74_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.45.120403.095920"},{"key":"e_1_3_2_3_75_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.319.5862.395"},{"key":"e_1_3_2_3_76_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-009-0949-1"},{"key":"e_1_3_2_3_77_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0809329"},{"key":"e_1_3_2_3_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.03.104"},{"key":"e_1_3_2_3_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(89)80689-8"},{"key":"e_1_3_2_3_80_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079907X210822"},{"key":"e_1_3_2_3_81_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-2-200901200-00005"},{"key":"e_1_3_2_3_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2005.04.017"},{"key":"e_1_3_2_3_83_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.596627"},{"key":"e_1_3_2_3_84_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.25.3051"},{"key":"e_1_3_2_3_85_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614133"},{"key":"e_1_3_2_3_86_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0809171"},{"key":"e_1_3_2_3_87_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.30.11.1288"},{"key":"e_1_3_2_3_88_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e3282f1b2be"},{"key":"e_1_3_2_3_89_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2008.20"},{"key":"e_1_3_2_3_90_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-013052"},{"key":"e_1_3_2_3_91_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000223867.25324.1a"},{"key":"e_1_3_2_3_92_1","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.9.9.1251"},{"key":"e_1_3_2_3_93_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-008-2291-6"},{"key":"e_1_3_2_3_94_1","doi-asserted-by":"publisher","DOI":"10.2217\/17410541.3.2.131"},{"key":"e_1_3_2_3_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2005.10.002"},{"key":"e_1_3_2_3_96_1","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.10.1.43"},{"key":"e_1_3_2_3_97_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.01937.x"},{"key":"e_1_3_2_3_98_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002280100359"},{"key":"e_1_3_2_3_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2004.01.004"},{"key":"e_1_3_2_3_100_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199702000-00008"},{"key":"e_1_3_2_3_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(99)70106-2"},{"key":"e_1_3_2_3_102_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199612000-00008"},{"key":"e_1_3_2_3_103_1","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.8.7.721"},{"key":"e_1_3_2_3_104_1","doi-asserted-by":"publisher","DOI":"10.2133\/dmpk.19.83"},{"issue":"2","key":"e_1_3_2_3_105_1","first-page":"124","article-title":"Allele frequency of CYP2C19 gene polymorphisms in a healthy Iranian population.","volume":"4","author":"Zand N","year":"2005","unstructured":"Zand N , TajikN, HoormandM, MoghaddamAS, MilanianI: Allele frequency of CYP2C19 gene polymorphisms in a healthy Iranian population.Iranian J. Pharmacol. Therap.s, 4(2), 124\u2013127 (2005).","journal-title":"Iranian J. Pharmacol. Therap.s"},{"key":"e_1_3_2_3_106_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.01883.x"},{"key":"e_1_3_2_3_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(98)90037-6"},{"key":"e_1_3_2_3_108_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-002-0425-x"},{"key":"e_1_3_2_3_109_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200204000-00006"},{"issue":"1","key":"e_1_3_2_3_110_1","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0022-3565(24)36606-6","article-title":"Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele.","volume":"281","author":"Xiao ZS","year":"1997","unstructured":"Xiao ZS , GoldsteinJA, XieHGet al.: Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele.J. Pharmacol. Exp. Ther., 281(1), 604\u2013609 (1997).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_3_2_3_111_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2007.03057.x"},{"key":"e_1_3_2_3_112_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1999.00009.x"},{"key":"e_1_3_2_3_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(98)90070-4"},{"key":"e_1_3_2_3_114_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1999.00019.x"},{"key":"e_1_3_2_3_115_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199612000-00005"},{"key":"e_1_3_2_3_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(98)90068-6"},{"key":"e_1_3_2_3_117_1","doi-asserted-by":"publisher","DOI":"10.1097\/01213011-199910000-00005"},{"issue":"4","key":"e_1_3_2_3_118_1","first-page":"357","article-title":"Prevalence of CYP2C19 gene polymorphisms in the Puerto Rican population: a preliminary report.","volume":"27","author":"Duconge J","year":"2008","unstructured":"Duconge J , CadillaCL, RentaJYet al.: Prevalence of CYP2C19 gene polymorphisms in the Puerto Rican population: a preliminary report.P.R. Health Sci. J., 27(4), 357\u2013358 (2008).","journal-title":"P.R. Health Sci. J."},{"key":"e_1_3_2_3_119_1","doi-asserted-by":"publisher","DOI":"10.1590\/S1984-82502009000300011"},{"key":"e_1_3_2_3_120_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2006.03.003"},{"key":"e_1_3_2_3_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.12.056"},{"key":"e_1_3_2_3_122_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1232"},{"key":"e_1_3_2_3_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61845-0"},{"key":"e_1_3_2_3_124_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808227"},{"key":"e_1_3_2_3_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.11.065"},{"key":"e_1_3_2_3_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.06.064"},{"key":"e_1_3_2_3_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2008.09.017"},{"key":"e_1_3_2_3_128_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.082001"},{"key":"e_1_3_2_3_129_1","unstructured":"Bhatt DL CryerB ContantCet al.; and COGENT Investigators. COGENT: A prospective randomized placebo-controlled trial of omeprazole in patients receiving aspirin and clopidogrel. Presented at: 21st Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium. San Francisco CA USA 21\u201326 September 2009."},{"key":"e_1_3_2_3_130_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60422-5"},{"key":"e_1_3_2_3_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61846-2"},{"key":"e_1_3_2_3_132_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.696732"},{"key":"e_1_3_2_3_133_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03733.x"},{"key":"e_1_3_2_3_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.06.038"},{"key":"e_1_3_2_3_135_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn046"},{"key":"e_1_3_2_3_136_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.812636"},{"key":"e_1_3_2_3_137_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.04.045"},{"key":"e_1_3_2_3_138_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.06.064"},{"key":"e_1_3_2_3_139_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.12.056"},{"key":"e_1_3_2_3_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2006.10.010"},{"key":"e_1_3_2_3_141_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.740324"},{"key":"e_1_3_2_3_142_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60441-4"},{"key":"e_1_3_2_3_143_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.851949"},{"key":"e_1_3_2_3_144_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706482"},{"key":"e_1_3_2_3_145_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.791061"},{"key":"e_1_3_2_3_146_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000199519.37089.a0"},{"key":"e_1_3_2_3_147_1","unstructured":"Bristol-Myers Squibb Pharma Company. Coumadin\u00ae label. 7 August 2007 revision (2007)."},{"key":"e_1_3_2_3_148_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-139-11-200312020-00007"},{"key":"e_1_3_2_3_149_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X05282640"},{"key":"e_1_3_2_3_150_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.104"},{"key":"e_1_3_2_3_151_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2005.04.017"},{"key":"e_1_3_2_3_152_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.09.125"},{"key":"e_1_3_2_4_2_1","unstructured":"Warfarin Dosing: a free website. www.warfarindosing.org\/Source\/Home.aspx"},{"key":"e_1_3_2_4_3_1","unstructured":"Ray T: FDA Clears ParagonDx\u2018s genetic warfarin assay; firm highlights same-day turnaround. Pharmacogenomics Reporter 6 19 (2008). www.genomeweb.com\/dxpgx\/fda-clears-paragondxs-genetic-warfarin-assay-firm-highlights-same-day-turnaround"},{"key":"e_1_3_2_4_4_1","unstructured":"Kimmel SE Rosenberg YD COAG Investigators. Clarification of Optimal Anticoagulation Through Genetics (COAG): A Randomized Multi-Center Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients. ClinicalTrial.gov website November 2009. http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00839657 (Accessed January112010)."},{"key":"e_1_3_2_4_5_1","unstructured":"Hudson KL Javitt GH: The case for genetic testing oversight. BioNews 21 August (2006). www.dnapolicy.org\/resources\/BioNews_8-21-06.pdf"},{"key":"e_1_3_2_4_6_1","unstructured":"Secretary\u2018s Advisory Committee on Genetics Health and Society: Coverage and Reimbursement of Genetic Tests and Services. Department of Health and Human Services. February (2006). http:\/\/oba.od.nih.gov\/oba\/sacghs\/reports\/CR_report.pdf"},{"key":"e_1_3_2_4_7_1","unstructured":"US Department of Health and Human Services. Draft Guidance for Industry Clinical Laboratories and FDA Staff: In vitro Diagnostic Multivariate Index Assays (2007). www.fda.gov\/downloads\/MedicalDevices\/DeviceRegulationandGuidance\/GuidanceDocuments\/ucm071455.pdf"},{"key":"e_1_3_2_4_8_1","unstructured":"US FDA: FDA clears genetic lab test for warfarin sensitivity (press release). FDA News (2008). www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/2007\/ucm108984.htm"}],"container-title":["Future Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fca.10.6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T20:39:22Z","timestamp":1740083962000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fca.10.6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":159,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["10.2217\/fca.10.6"],"URL":"https:\/\/doi.org\/10.2217\/fca.10.6","relation":{},"ISSN":["1479-6678","1744-8298"],"issn-type":[{"value":"1479-6678","type":"print"},{"value":"1744-8298","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}